Deficiency/Longevity/Heart

Vitamin K

Fat-soluble vitamin that supports normal clotting and may help bone and vascular health in adults with low intake.

Vitamin K

Vitamin K

72
score
B
evidence
Caution
risk

Proven Benefits

01Corrects low vitamin K status
02Supports bone density
03May reduce arterial stiffness
04May reduce fracture risk
05May slow vascular calcification
06May improve insulin sensitivity
07May lower hs-CRP / IL-6

Chemical Forms

Recommended
  • Vitamin K2 (MK-7)
  • Vitamin K1 (phylloquinone)
  • Vitamin K2 (MK-4)
Avoid
  • Vitamin K3 / menadione (synthetic; potential toxicity and not for routine human supplementation)
Expert Note

K1 covers basic nutritional intake and clotting needs, while K2 as MK-7 has a longer half-life and more consistently raises extrahepatic vitamin K markers at once-daily doses. MK-4 is clinically studied but has a short half-life and is usually used in much higher split doses. Menadione is avoided because of safety concerns.

Protocol

Amount
90-180 mcg
Frequency
Once daily
When
With a meal containing fat to improve absorption.

Condition-Based Dosing

Healthy adults with low dietary vitamin K intake
90-120 mcg/day of vitamin K1 or 90-180 mcg/day of MK-7
Adults using vitamin D3 for bone support
90-180 mcg/day of vitamin K2 as MK-7
High-dose MK-4 bone protocols
45 mg/day of MK-4 split into 3 doses

Safety & Limits

Upper Safe Limit
No established UL for vitamin K1/K2 (NASEM/IOM); common OTC doses 90-200 mcg/day are generally well tolerated.
Cycling
Safe for continuous use

Contraindications

Warfarin, acenocoumarol, or phenprocoumon — abrupt intake changes can lower INR and reduce anticoagulant effect
Mechanical heart valve or history of unstable INR — supplement only with clinician-guided anticoagulant adjustment
Severe cholestatic liver disease or fat-malabsorption disorders — dosing and monitoring may need medical supervision
Planned surgery while on anticoagulants — keep intake stable and coordinate changes with the prescriber

Synergies

Vitamin D increases production of osteocalcin and other K-dependent proteins; vitamin K helps carboxylate them so calcium is used more effectively in bone.

Vitamin K activates osteocalcin, which helps bind calcium into bone, so the pairing works best when calcium intake is adequate.

Avoid Combining With

  • Warfarin and similar vitamin K antagonists (directly oppose vitamin K recycling; only change intake with clinician oversight)
  • Orlistat (reduces fat absorption and lowers vitamin K uptake)
  • Bile acid sequestrants like cholestyramine (impair absorption of fat-soluble vitamins)
  • High-dose vitamin E (can oppose vitamin K-dependent clotting activity)
  • Very low-fat meals (reduce absorption; take vitamin K with food containing fat)
Updated Invalid Date